![Peter Åsberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Åsberg
Vorstandsvorsitzender bei Disruptive Pharma AB
Ursprung des Netzwerks ersten Grades von Peter Åsberg
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Disruptive Pharma AB
![]() Disruptive Pharma AB Pharmaceuticals: MajorHealth Technology Disruptive Pharma AB is a pharmaceutical company based in Uppsala, Sweden, with a passion for innovation in drug products. The Swedish company has perfected the groundbreaking mesoporous magnesium carbonate (mmc) drug delivery technology, which makes it easier to develop amorphous drug candidates. By combining the mmc formulation technology with drug compounds, they can enhance existing products or assist in formulating new therapies. Disruptive Pharma seeks commercial partnership or licensing to industry partners within the drug improvement business area. The company was founded in 2018 by Maria Strömme, and the CEO is Peter Åsberg.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter Åsberg
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
SECURITAS AB | Miscellaneous Commercial Services | Chairman | |
AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member | |
Athera Biotechnologies AB
![]() Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Royal Swedish Academy of Sciences
![]() Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Axel Johnson AB
![]() Axel Johnson AB Miscellaneous Commercial ServicesCommercial Services Axel Johnson AB engages in the food, industrial, information technology, and health and wellness businesses. Its portfolio companies include Axfood, Axsol, Dustin, Kicks, Martin & Servera, Novax, SkinCity, and Åhléns. The company was founded by Axel Axelsson Johnson in 1873 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Karolinska Institutet | College/University | Corporate Officer/Principal | |
OREXO AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Royal Swedish Academy of Engineering Sciences
![]() Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Altimmune UK Ltd.
![]() Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
BONESUPPORT HOLDING AB | Medical Specialties | Corporate Officer/Principal | |
AnaMar AB
![]() AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biosergen AS
![]() Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chief Executive Officer | |
LIPIDOR AB | Miscellaneous Commercial Services | Director/Board Member | |
NovaSAID AB
![]() NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Operating Officer | |
Palette Life Sciences AB
![]() Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member | |
Cenova AB
![]() Cenova AB Miscellaneous ManufacturingProducer Manufacturing Cenova AB is a contract manufacturer with 50 years of experience in innovative and complex cleanroom manufacturing of plastic products. The private company is based in Mjölby, Sweden. The Swedish company's focus is on injection molding, vacuum forming, assembly, packaging, and sterilization. The company has the expertise and technology to manufacture products according to the market's toughest standards. The CEO of the company is Fredrik Holmgren. | Miscellaneous Manufacturing | Director/Board Member | |
Swednano Tech AB
![]() Swednano Tech AB Financial ConglomeratesFinance Swednano Tech AB provides financial support services. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Analgesia Partnership | Corporate Officer/Principal | ||
HealthCap Advisor AB
![]() HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal | |
Disruptive Materials AB
![]() Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden. | Chemicals: Major Diversified | Director/Board Member Founder | |
GABATHER AB | Pharmaceuticals: Major | Director/Board Member | |
Ancilla AB
![]() Ancilla AB Real Estate DevelopmentFinance Ancilla AB manages real properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member | |
Immuneed AB
![]() Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Chief Executive Officer | |
EMPLICURE AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
SP Process Development AB | Director/Board Member | ||
INITIATOR PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Healthcap Aero Holdings Gp | Director/Board Member | ||
Healthcap Orx Holdings Gp AB
![]() Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Healthcap Orx Holdings Gp AB is a private company that manages securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Trimb Holding AB
![]() Trimb Holding AB Financial ConglomeratesFinance Part of Karo Healthcare AB, Trimb Holding AB operates as a holding Swedish company with interest in pharmaceuticals. The company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Skipjack AB
![]() Skipjack AB Real Estate DevelopmentFinance Skipjack AB Manages real properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Healthcap Annex Fund I-Ii Bis Gp AB
![]() Healthcap Annex Fund I-Ii Bis Gp AB Financial ConglomeratesFinance Healthcap Annex Fund I-Ii Bis Gp AB operates as an investment holding Swedish company. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Haracon AB
![]() Haracon AB Miscellaneous Commercial ServicesCommercial Services Haracon AB provides corporate consulting services. | Miscellaneous Commercial Services | Director/Board Member | |
Gesynta Pharma AB
![]() Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder | |
INIM Pharma AB
![]() INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
EllAug AB | Director/Board Member | ||
Synox Therapeutics Ltd.
![]() Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Biotechnology | Director/Board Member | |
Tribune Therapeutics AB
![]() Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Mips Helmet AB | Director/Board Member | ||
Aurelia Invest AB | Director/Board Member | ||
Strike Pharma AB
![]() Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Biolin Scientific Holding AB
![]() Biolin Scientific Holding AB Pharmaceuticals: MajorHealth Technology Part of Quartzin Intressenter AB, Biolin Scientific Holding AB is a company that manufactures pharmaceutical products. The company is based in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Schweden | 43 |
Luxemburg | 2 |
Vereinigtes Königreich | 2 |
Schweiz | 2 |
Norwegen | 2 |
Sektoral
Health Technology | 21 |
Commercial Services | 10 |
Finance | 10 |
Electronic Technology | 2 |
Consumer Services | 2 |
Operativ
Director/Board Member | 77 |
Independent Dir/Board Member | 14 |
Chairman | 12 |
Corporate Officer/Principal | 12 |
Chief Executive Officer | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Peter Åsberg
- Unternehmensverbindungen